• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Intensive Care Med . Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Relat

tetano

Editor, Senior Moderator
J Intensive Care Med


. 2024 Feb 28:8850666241233189.
doi: 10.1177/08850666241233189. Online ahead of print. Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network

Jaime Fernández-Sarmiento[SUP] 1 [/SUP], Lorena Acevedo[SUP] 1 [/SUP], Laura Fernanda Niño-Serna[SUP] 2 [/SUP], Raquel Boza[SUP] 3 [/SUP], Jimena García-Silva[SUP] 4 [/SUP], Adriana Yock-Corrales[SUP] 5 [/SUP], Marco A Yamazaki-Nakashimada[SUP] 6 [/SUP], Enrique Faugier-Fuentes[SUP] 7 [/SUP], Olguita Del Águila[SUP] 8 [/SUP], German Camacho-Moreno[SUP] 9 [/SUP], Dora Estripeaut[SUP] 10 [/SUP], Iván F Gutiérrez[SUP] 11 [/SUP], Kathia Luciani[SUP] 12 [/SUP], Graciela Espada[SUP] 13 [/SUP], Martha I Álvarez-Olmos[SUP] 14 [/SUP], Paola Pérez-Camacho[SUP] 15 [/SUP], Saulo Duarte-Passos[SUP] 16 [/SUP], Maria C Cervi[SUP] 17 [/SUP], Edwin M Cantillano[SUP] 18 [/SUP], Beatriz A Llamas-Guillén[SUP] 19 [/SUP], Patricia Saltigeral-Simental[SUP] 20 [/SUP], Javier Criales[SUP] 21 [/SUP], Enrique Chacon-Cruz[SUP] 22 23 [/SUP], Miguel García-Domínguez[SUP] 24 [/SUP], Karla L Borjas Aguilar[SUP] 25 [/SUP], Daniel Jarovsky[SUP] 26 [/SUP], Gabriela Ivankovich-Escoto[SUP] 27 [/SUP], Adriana H Tremoulet[SUP] 28 [/SUP], Rolando Ulloa-Gutierrez[SUP] 29 30 31 [/SUP]; REKAMLATINA-3 Study Group Investigators 32



Affiliations
Abstract

Background: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 varies widely in its presentation and severity, with low mortality in high-income countries. In this study in 16 Latin American countries, we sought to characterize patients with MIS-C in the pediatric intensive care unit (PICU) compared with those hospitalized on the general wards and analyze the factors associated with severity, outcomes, and treatment received. Study Design: An observational ambispective cohort study was conducted including children 1 month to 18 years old in 84 hospitals from the REKAMLATINA network from January 2020 to June 2022. Results: A total of 1239 children with MIS-C were included. The median age was 6.5 years (IQR 2.5-10.1). Eighty-four percent (1043/1239) were previously healthy. Forty-eight percent (590/1239) were admitted to the PICU. These patients had more myocardial dysfunction (20% vs 4%; P < 0.01) with no difference in the frequency of coronary abnormalities (P = 0.77) when compared to general ward subjects. Of the children in the PICU, 83.4% (494/589) required vasoactive drugs, and 43.4% (256/589) invasive mechanical ventilation, due to respiratory failure and pneumonia (57% vs 32%; P = 0.01). On multivariate analysis, the factors associated with the need for PICU transfer were age over 6 years (aOR 1.76 95% CI 1.25-2.49), shock (aOR 7.06 95% CI 5.14-9.80), seizures (aOR 2.44 95% CI 1.14-5.36), thrombocytopenia (aOR 2.43 95% CI 1.77-3.34), elevated C-reactive protein (aOR 1.89 95% CI 1.29-2.79), and chest x-ray abnormalities (aOR 2.29 95% CI 1.67-3.13). The overall mortality was 4.8%. Conclusions: Children with MIS-C who have the highest risk of being admitted to a PICU in Latin American countries are those over age six, with shock, seizures, a more robust inflammatory response, and chest x-ray abnormalities. The mortality rate is five times greater when compared with high-income countries, despite a high proportion of patients receiving adequate treatment.

Keywords: COVID-19; Latin America; MIS-C; PIMS-TS; SARS-CoV2; children; critical care; inflammatory; mortality; shock.

 
Back
Top Bottom